Follow us on:
Breaking News
March 4, 2026
Breaking News
Breaking News
Adare_ENL_031126_650x90

CordenPharma Colorado Leases Space at Flatiron Park Campus

 
CordenPharma Colorado Leases Space at Flatiron Park Campus

Will house process development and analytical services for advanced peptide API production from development through commercialization.
Read More >>

Headlines

Breaking News

Novo Nordisk Announces $372.5M Expansion in Monksland, Athlone, Ireland

The investment will support the upgrade and retrofit of the existing facility and enhance Novo Nordisk’s capacity to manufacture oral GLP-1s.

SPONSOR

Enhance API Solubility with 3DP and mesoporous silica

3D printing with mesoporous silica enhances tablet design flexibility and improves solubility for poorly soluble APIs. View the data.

Breaking News

ESTEVE CDMO Begins $15.5M Expansion of Chicago Small Molecule API Facility

Site provides process R&D, analytical and stability testing, cGMP API manufacturing, and CMC support.

Breaking News

Sino Biopharm Licenses Rovadicitinib to Sanofi for up to $1.5B

Rovadicitinib is approved in China for myelofibrosis and is in late-stage development for chronic graft-versus-host disease.

SPONSOR

Pharmaceutical Formulation 2026: Patient-Centric, Personalized, and Powered by Innovation

Learn how advanced science, digital design, and collaborative CDMOs are redefining the future of drug delivery.

BoraPharmaceuticals_ENL_0326_650x250

Breaking News

Teva, Blackstone Life Sciences Enter $400M Funding Agreement for Duvakitug

Duvakitug is currently in phase 3 trials for ulcerative colitis and Crohn’s disease.

SPONSOR

Decentralized Clinical Trials Outlook

In this eBook from Contract Pharma and IQVIA, explore the importance of fine-tuning patient-centered DCT solutions with evolving site roles and perspectives in mind.

Featured Resources

Solution Content Centers SPOTLIGHT

Adare Pharma Solutions

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Adare’s specialized technology platforms provide taste masking, customized release, multiparticulate systems, and patient-centric dosing solutions. With a proven history in drug delivery, Adare’s facilities in the US and Europe have developed and manufactured more than sixty-five products sold by customers worldwide.

 

Solution Content Centers SPOTLIGHT

IDT Biologika

IDT Biologika is a global CDMO for vaccines, recombinant proteins, viral vectors, gene & immune therapeutics, monoclonal antibodies, oncolytic viruses and other sterile injectables. End-to-end services in process development, drug substance manufacturing, fill&finish, packaging, quality control and analytics.